OpGen (OPGN) Competitors $0.0001 0.00 (0.00%) As of 01:32 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock OPGN vs. UPHL, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, TALKW, and TOIIWShould you be buying OpGen stock or one of its competitors? The main competitors of OpGen include UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry. OpGen vs. Its Competitors UpHealth Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute UpHealth (NYSE:UPHL) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment. Does the media refer more to UPHL or OPGN? In the previous week, UpHealth's average media sentiment score of 0.00 equaled OpGen'saverage media sentiment score. Company Overall Sentiment UpHealth Neutral OpGen Neutral Do insiders and institutionals believe in UPHL or OPGN? 56.1% of UpHealth shares are held by institutional investors. Comparatively, 2.7% of OpGen shares are held by institutional investors. 34.2% of UpHealth shares are held by insiders. Comparatively, 43.8% of OpGen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, UPHL or OPGN? UpHealth has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, OpGen has a beta of -1.77, meaning that its stock price is 277% less volatile than the S&P 500. Is UPHL or OPGN more profitable? UpHealth has a net margin of 0.00% compared to OpGen's net margin of -1,140.36%. Company Net Margins Return on Equity Return on Assets UpHealthN/A N/A N/A OpGen -1,140.36%N/A -287.58% Which has preferable earnings & valuation, UPHL or OPGN? OpGen has lower revenue, but higher earnings than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpHealth$130M0.00-$56.42M-$1.350.00OpGen$2.67M0.00-$32.67MN/AN/A SummaryUpHealth beats OpGen on 5 of the 8 factors compared between the two stocks. Get OpGen News Delivered to You Automatically Sign up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OPGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPGN vs. The Competition Export to ExcelMetricOpGenMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$614.50K$5.66B$10.35BDividend YieldN/AN/A5.75%4.64%P/E RatioN/AN/A76.2226.09Price / Sales0.000.92559.23125.64Price / CashN/AN/A37.6061.24Price / Book0.000.1112.376.33Net Income-$32.67M-$27.68M$3.29B$270.93M7 Day PerformanceN/AN/A1.07%0.17%1 Month PerformanceN/AN/A3.59%6.15%1 Year PerformanceN/AN/A60.72%28.28% OpGen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPGNOpGenN/A$0.00flatN/AN/A$1K$2.67M0.00100High Trading VolumeUPHLUpHealthN/A$0.00flatN/A-99.5%$4K$130M0.001,750ACONWAclarionN/A$0.03+0.3%N/A+12.9%$0.00$62.95K0.007News CoverageGap DownAONCAmerican Oncology NetworkN/A$10.45-1.8%N/A+137.0%$0.00$1.34B0.001,520High Trading VolumeDHACWDigital Health AcquisitionN/A$0.03+30.8%N/A-15.0%$0.00N/A0.00N/AGap UpFMSFresenius Medical Care AG & Co. KGaA3.5054 of 5 stars$25.68+0.1%$27.80+8.3%+19.7%$0.00$20.63B21.051,384LFMDPLifeMDN/A$23.97flatN/A+9.1%$0.00$245.56M0.00230News CoveragePositive NewsDividend CutOTRKPOntrakN/A$0.04+75.0%N/A-84.2%$0.00$10.84M0.00250Gap DownHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01+25.0%N/A-63.1%$0.00$1.46B0.00500Gap DownTALKWTalkspaceN/A$0.07+1.6%N/A-14.4%$0.00$202.61M0.00500High Trading VolumeTOIIWOncology InstituteN/A$0.10-0.5%N/A+490.4%$0.00$424.38M0.00660Gap Down Related Companies and Tools Related Companies UPHL Competitors ACONW Competitors AONC Competitors DHACW Competitors FMS Competitors LFMDP Competitors OTRKP Competitors PIIIW Competitors TALKW Competitors TOIIW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OPGN) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OpGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OpGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPGN Stock Alerts